JPH02309241A - Adrenalin detection sensor - Google Patents
Adrenalin detection sensorInfo
- Publication number
- JPH02309241A JPH02309241A JP1130818A JP13081889A JPH02309241A JP H02309241 A JPH02309241 A JP H02309241A JP 1130818 A JP1130818 A JP 1130818A JP 13081889 A JP13081889 A JP 13081889A JP H02309241 A JPH02309241 A JP H02309241A
- Authority
- JP
- Japan
- Prior art keywords
- adrenaline
- electrode
- film
- drain
- adrenalinmonoamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- UCTWMZQNUQWSLP-UHFFFAOYSA-N Adrenaline Natural products CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 title claims abstract description 66
- 238000001514 detection method Methods 0.000 title claims abstract description 12
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 title abstract 4
- 229940102884 adrenalin Drugs 0.000 title abstract 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims abstract description 10
- 102000010909 Monoamine Oxidase Human genes 0.000 claims description 9
- 108010062431 Monoamine oxidase Proteins 0.000 claims description 9
- 239000012528 membrane Substances 0.000 claims description 7
- 230000000694 effects Effects 0.000 claims description 6
- 230000005669 field effect Effects 0.000 claims description 4
- 238000001139 pH measurement Methods 0.000 claims 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 abstract description 5
- 229910052710 silicon Inorganic materials 0.000 abstract description 5
- 239000010703 silicon Substances 0.000 abstract description 5
- 239000000758 substrate Substances 0.000 abstract description 5
- 230000003647 oxidation Effects 0.000 abstract description 4
- 238000007254 oxidation reaction Methods 0.000 abstract description 4
- 229910052581 Si3N4 Inorganic materials 0.000 abstract description 3
- 239000011347 resin Substances 0.000 abstract description 3
- 229920005989 resin Polymers 0.000 abstract description 3
- 102000004316 Oxidoreductases Human genes 0.000 abstract 2
- 108090000854 Oxidoreductases Proteins 0.000 abstract 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 2
- 238000005229 chemical vapour deposition Methods 0.000 abstract 1
- 229910052681 coesite Inorganic materials 0.000 abstract 1
- 229910052906 cristobalite Inorganic materials 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000000377 silicon dioxide Substances 0.000 abstract 1
- 235000012239 silicon dioxide Nutrition 0.000 abstract 1
- 229910052682 stishovite Inorganic materials 0.000 abstract 1
- 229910052905 tridymite Inorganic materials 0.000 abstract 1
- 238000007740 vapor deposition Methods 0.000 abstract 1
- 238000005259 measurement Methods 0.000 description 10
- 239000000243 solution Substances 0.000 description 9
- 239000000126 substance Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 4
- 108091006146 Channels Proteins 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 238000004811 liquid chromatography Methods 0.000 description 3
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- 108010075750 P-Type Calcium Channels Proteins 0.000 description 2
- 206010039966 Senile dementia Diseases 0.000 description 2
- 125000003172 aldehyde group Chemical group 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 150000003943 catecholamines Chemical class 0.000 description 2
- 229960003638 dopamine Drugs 0.000 description 2
- 238000000840 electrochemical analysis Methods 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- HMJBXEZHJUYJQY-UHFFFAOYSA-N 4-(aminomethyl)octane-1,8-diamine Chemical compound NCCCCC(CN)CCCN HMJBXEZHJUYJQY-UHFFFAOYSA-N 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 229920002284 Cellulose triacetate Polymers 0.000 description 1
- QWCKQJZIFLGMSD-GSVOUGTGSA-N D-alpha-aminobutyric acid Chemical compound CC[C@@H](N)C(O)=O QWCKQJZIFLGMSD-GSVOUGTGSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 210000001943 adrenal medulla Anatomy 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 238000004313 potentiometry Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 229910052594 sapphire Inorganic materials 0.000 description 1
- 239000010980 sapphire Substances 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
Abstract
Description
【発明の詳細な説明】
産業上の利用分野
本発明は、アセチルコリン、ドーパミン、セロトニン、
r−アミノ酪酸、グルタミン酸等の他の物質が混在して
もアドレナリンのみに感じ、老人痴呆関連物質の一つと
して注目され、副腎髄質細胞や脳や末梢の神経細胞に存
在しているアドレナリンの濃度を検出するアドレナリン
検出センサに関するものである。DETAILED DESCRIPTION OF THE INVENTION Field of Industrial Application The present invention is applicable to acetylcholine, dopamine, serotonin,
Even if other substances such as r-aminobutyric acid and glutamic acid are mixed, only adrenaline is felt, and it is attracting attention as one of the substances related to senile dementia, and the concentration of adrenaline present in adrenal medulla cells, brain and peripheral nerve cells. This invention relates to an adrenaline detection sensor that detects adrenaline.
従来の技術
老人痴呆関連物質の一つとして注目されており、現在は
ヒトの脳を髄液から取り出し、パーキンソン病患者にお
いてはこの物質が減少していることが見い出されている
アドレナリンの検出は、従来、分離法として液体クロマ
トグラフィーを、定量法として電気化学分析手法の一つ
であるアンベロメトリー法とを使い、これらを併用して
いた。液体クロマトグラフィーはカラム中の吸着剤によ
って吸着力の差によって流出する成分の時間差を利用し
て分離を行なうもので、分離されたものを電気化学検出
器に導かれた0、65〜1.OV程度の直流T2C圧を
動作極をアノードとして印加すると、流れる電流は第5
図のようになり、この電流はアドレナリンを含むカテコ
ールアミンおよびその代謝物の酸化によるもので、その
ピークがそれぞれの濃度に比例することを利用して定量
を行なうものである。Conventional technology The detection of adrenaline, which has been attracting attention as one of the substances associated with senile dementia, is currently being conducted by extracting human brains from the spinal fluid and finding that this substance is reduced in Parkinson's disease patients. Conventionally, liquid chromatography has been used as a separation method, and amberometry, which is an electrochemical analysis method, has been used as a quantitative method, and these have been used in combination. Liquid chromatography performs separation by utilizing the time difference between the components flowing out due to the difference in adsorption power by the adsorbent in the column, and the separated components are introduced into an electrochemical detector. When applying a DC T2C pressure of about OV with the working pole as the anode, the current flowing is the fifth
As shown in the figure, this current is due to the oxidation of catecholamines and their metabolites, including adrenaline, and is quantified by utilizing the fact that their peaks are proportional to their respective concentrations.
発明が解決しようとする課題
従来の方法は前述したように生体から髄液を取り出して
分離・定量するものであシ、体内の局所情報を直接計測
したものではない。もし、この方法で体内情報を得るよ
うにするためには装置を小型化しなければならないし、
それは事実上不可能である。また、検体に直接電流を流
すことは、人体にとって安全であるという保障はない。Problems to be Solved by the Invention As mentioned above, conventional methods involve extracting, separating, and quantifying cerebrospinal fluid from a living body, and do not directly measure local information within the body. If we were to obtain internal information using this method, the device would have to be made smaller.
It's virtually impossible. Furthermore, there is no guarantee that passing an electric current directly through a specimen is safe for the human body.
また、液体クロマトグラフィー/電気化学分析法による
検出装置が大型であること、外的温度変化を防ぐために
、アンヘロメトリー検出器を恒温室内に入れ、検出器予
備ヒーターを10.04℃以下の厳密な温度安定性にし
なければならないため、温度制御が繁雑であり、′シた
がって、コストが高いという問題があった。In addition, the detection equipment using liquid chromatography/electrochemical analysis is large, and in order to prevent external temperature changes, the anherometry detector is placed in a constant temperature room, and the pre-heater for the detector is kept strictly at 10.04℃ or less. Since temperature stability must be maintained, temperature control is complicated and, therefore, the cost is high.
本発明は従来法に述べた欠点を解消するために、フラビ
ン含有のアドレナリンモノアミンオキシダーゼの作用に
より、アドレナリンのみと反応して、その濃度に比例す
る3−4−ジヒドロキシマンデル酸を形成せしめ、それ
によるpH変化をポテンションメトリー法によシ測定し
、小型でかつ測定が簡単で、安価なアドレナリン検出セ
ンサを提供するものである。なお、この検出センサはイ
ンビボ(in vivo (生体内)〕においても
測定可能である。In order to eliminate the drawbacks mentioned in the conventional method, the present invention reacts only with adrenaline to form 3-4-dihydroxymandelic acid in proportion to the concentration of adrenaline by the action of flavin-containing adrenaline monoamine oxidase. The object of the present invention is to provide an adrenaline detection sensor that measures pH changes using a potentiometry method, is small, easy to measure, and inexpensive. Note that this detection sensor can also perform measurements in vivo.
課題を解決するための手段
上記目的を達成するため、本発明の技術的解決手段は、
一つの基板上にフラビン含有のアドレナリンモノアミン
オキシダーゼを固定化した膜で覆った測定pH−l5F
ET(イオン感応性電界効果トランジスタ)と固定化膜
をつけない参照pH−I S FETの2つを用意し、
環境温度やpHを補償することによって、純粋にアドレ
ナリンのみに感じて、その濃度を指示するようにしたも
のである。Means for Solving the Problems In order to achieve the above object, the technical solution of the present invention is as follows:
Measurement pH-15F covered with a membrane containing flavin-containing adrenaline monoamine oxidase immobilized on one substrate
Prepare two types: an ET (ion-sensitive field effect transistor) and a reference pH-I S FET without an immobilization film.
By compensating for environmental temperature and pH, it senses pure adrenaline and indicates its concentration.
作 用
本発明はいろいろな物質が共存していてもアドレナリン
のみがフラビン含有のアドレナリンモノアミンオキシダ
ーゼによって分解し、3−4−ジヒドロキシマンデル酸
を形成する。それにより膜の内部では外部に存在するア
ドレナリンの濃度に応じてpHが変化する。そうすると
ゲー)[圧は、ネルンストの式により
E = (RT/F )・1ogpH
ここで、Rは気体定数、Tは給体温度、Fはファラデ一
定数
のように変化し、F]liTのチャンネルに電子が誘起
され、ソース・ドレイン間に電流が流れ、この電流は外
部溶液pHが変わっても温度が変わっても変化を受ける
ので、電解液pHと温度のみに感じるpH−FBTを並
列に設けることによりブツンユプル差動回路によってそ
れを補償して溶液中のアドレナリンのみの濃度を検出す
るものである。Effects According to the present invention, even if various substances are present, only adrenaline is decomposed by flavin-containing adrenaline monoamine oxidase to form 3-4-dihydroxymandelic acid. As a result, the pH inside the membrane changes depending on the concentration of adrenaline present outside. Then, the pressure changes as E = (RT/F)・1ogpH according to the Nernst equation, where R is the gas constant, T is the feed temperature, F is the Faraday constant, and the channel of F]liT electrons are induced, and a current flows between the source and drain, and this current changes even if the external solution pH changes or the temperature changes, so a pH-FBT that is sensitive only to the electrolyte pH and temperature is installed in parallel. This is compensated by a differential circuit to detect only the concentration of adrenaline in the solution.
実施例 以下に本発明の実施例を図面を用いて詳細に説明する。Example Embodiments of the present invention will be described in detail below with reference to the drawings.
第1図<a>は測定pH−l5FET (4オン感応性
電界効果トランジスタ)を上から見た図で、同図(b)
は(a)の!−1′における断面図である。1はP−型
シリコン基板である。2.2′はそれにリンを拡散によ
シドーブして作ったドレイン、ソースn+領域である。Figure 1 <a> is a top view of the measured pH-15FET (4-on sensitive field effect transistor), and Figure 1 (b)
is (a)! It is a sectional view at -1'. 1 is a P-type silicon substrate. 2.2' is a drain and source n+ region formed by doping phosphorus thereon by diffusion.
3はP−型のチャンネル部分である。4は先端のゲート
部分以外の表面に形成されたホウ素を拡散したP のチ
ャンネルストッパーである。5はドレイン電極でAu−
Crを蒸着したものである。6はソース電極でAu−C
rを蒸着したものである。5.6はそれぞれドレイン、
ソース電極Aj端子である。7は加熱酸化によって素子
表面に形成した8i02被膜である。8Fi、C■法に
よ多形成したSi3N4 被膜である。9はゲート部分
以外をモールド化したエポキシとシリコンの混合樹脂で
ある。10はドーパミンのみに反応するフラビン含有の
アドレナリンモノアミンオキシダーゼ固定化膜である。3 is a P-type channel portion. 4 is a P channel stopper in which boron is diffused and formed on the surface other than the gate portion at the tip. 5 is the drain electrode made of Au-
Cr is vapor-deposited. 6 is the source electrode made of Au-C
It has been vapor-deposited with r. 5.6 is the drain, respectively.
This is the source electrode Aj terminal. 7 is an 8i02 film formed on the element surface by thermal oxidation. This is a Si3N4 film formed by the 8Fi, C■ method. 9 is a mixed resin of epoxy and silicon which is molded except for the gate portion. 10 is a flavin-containing adrenaline monoamine oxidase-immobilized membrane that reacts only with dopamine.
第2図は参照pH−l5FE’I’ (イオン感応性電
界効果トランジスタ)の構成を示し、第2図(a)は平
面図、第2図(b)は同図(a)の1−1における断面
図である。参照pH−l5F’B’rは第1図に示した
測定pH−l8FETとほぼ同一の構成をしており、ゲ
ート部に固定化膜が設けられていない点で異なる。Figure 2 shows the configuration of the reference pH-l5FE'I' (ion-sensitive field effect transistor), where Figure 2 (a) is a plan view and Figure 2 (b) is 1-1 in Figure 2 (a). FIG. The reference pH-15F'B'r has almost the same configuration as the measurement pH-18FET shown in FIG. 1, and differs in that no immobilization film is provided at the gate portion.
次に、フラビン含有のアドレナリンモノアミンオキシダ
ーゼを膜に固定化する方法を述べる〇(3−アミノプロ
ピル)トリエトキシシランと水との10=1溶液にIM
HcJを加えてpH7に調整し、水浴上で50℃に加熱
した浴中にゲート電極部分を2hr浸漬反応させてSi
3N4 を化学修飾する。化学修飾させたゲート電極
をセルローズトリアセテート250 mgをジクロメタ
ン10rMに溶解し、さらに50 %のグルタルアルデ
ヒド100μl と4−アミノメチル−1,8−オクタ
ンジアミン500μlを加えた溶液に浸漬して後、デシ
ケータ中で1日保存して架橋反応を進行させる。さらに
1チのグルタルアルデヒド溶液と室温で1hr反応させ
て有機皮膜の表面にアルデヒド基を導入し、pH7のリ
ン酸緩衝液で充分洗浄してからサファイア基板pH−F
ETゲートを4℃のフラビ。Next, we will describe a method for immobilizing flavin-containing adrenaline monoamine oxidase onto a membrane.
The pH was adjusted to 7 by adding HcJ, and the gate electrode was immersed in a water bath heated to 50°C for 2 hours to react.
Chemically modify 3N4. The chemically modified gate electrode was immersed in a solution containing 250 mg of cellulose triacetate dissolved in 10 rM dichloromethane, 100 μl of 50% glutaraldehyde and 500 μl of 4-aminomethyl-1,8-octanediamine, and then placed in a desiccator. Store it for one day to allow the crosslinking reaction to proceed. Furthermore, aldehyde groups were introduced onto the surface of the organic film by reacting with 100% glutaraldehyde solution at room temperature for 1 hour, and after thorough washing with a pH 7 phosphate buffer, the sapphire substrate pH-F
Flavi the ET gate at 4°C.
含有のアドレナリンモノアミンオキシダーゼを分散させ
た飽和溶液の中に浸漬して、アミノ基とアルデヒド基を
置換することにより、フラビン含有のアドレナリンモノ
アミンオキシダーゼをgK固定する。The flavin-containing adrenaline monoamine oxidase is immobilized with gK by substituting the amino group and the aldehyde group by immersing it in a saturated solution in which the adrenaline monoamine oxidase contained therein is dispersed.
第3図は、アドレナリン検出用pH−l5FETの測定
回路図で、定電流源20により、測定pH−l5FET
IIに常に一定のドレイン電流Idが流れ、別の電流源
18によシ測定pH−l5FBT 11のソース、ドレ
イン間に一定電圧Vd=RIlが印加されている。溶液
中のpH変化により界面電位が変化シテモ、ff1ll
定pH−l5F’BT 11 (7) Id、 Vd7
)f変化できないため、ソース、ドレイン間の電位が共
に界面電位変化分だけ変わl)、Voutzにその変化
が出力される。溶液の濃度変化や均一なpH変化に対す
る応答特性をよくするために、同様にして参照pH−l
5FET KよるVoutzを出力さセル。FIG. 3 is a measurement circuit diagram of the pH-15FET for detecting adrenaline.
A constant drain current Id always flows through II, and a constant voltage Vd=RI1 is applied between the source and drain of the pH-15FBT 11 for measurement by another current source 18. The interfacial potential changes due to pH changes in the solution.
Constant pH-15F'BT 11 (7) Id, Vd7
) Since f cannot change, the potentials between the source and drain both change by the amount of the interface potential change l), and this change is output to Voutz. In order to improve the response characteristics to changes in the concentration of the solution and uniform pH changes, the reference pH-l
5FET K outputs Voutz cell.
24Fiその差を取るための差動増幅器である。24Fi is a differential amplifier for taking the difference.
測定方法は、まず微小なマイクロンリンジをセットし、
この中に体液をわずか(量Fi、0.5μlりに取り出
して、フラビン含有のアドレナリンモノアミンオキシダ
ーゼを固定化した測定p、H−ISFET11 と固
定化しない裸のpH−l5FET(参照l5FET )
12とAgの表面を塩化物化しだAg/AgC1基準
極13の3電極を液絡させる。オペアンプ14.15.
16.17 によって画工5FET11.12に常に1
0μAのドレイン電流を流し、ソース・ドレイン間に電
流源18.19.20.21 及び抵抗22.23に
よシ一定の直流電圧(1〜2v)がかかるようにする。The measurement method is to first set a small micro ring,
A small amount of body fluid (amount Fi, 0.5 μl) was taken out into this, and the measurement p, H-ISFET11 with flavin-containing adrenaline monoamine oxidase immobilized and the bare pH-15FET without immobilization (reference 15FET)
The surfaces of Ag and Ag are chlorinated and the three electrodes of Ag/AgC1 reference electrode 13 are brought into liquid junction. Operational amplifier 14.15.
16.17 Always 1 to painter 5FET11.12 by
A drain current of 0 μA is caused to flow, and a constant DC voltage (1 to 2 V) is applied between the source and drain through the current source 18, 19, 20, 21 and the resistor 22, 23.
そうすると、それぞれのpH−l5FET 検出センサ
のゲート絶縁部は、I 5FETの原理によpsio2
絶縁層と電解液の境界面で、イオン濃度による界面電位
が発生し、これがシリコン表面に印加され、ドレイン電
極が変化する。Then, the gate insulating part of each pH-15FET detection sensor is psio2 according to the principle of I5FET.
At the interface between the insulating layer and the electrolyte, an interfacial potential is generated due to the ion concentration, and this is applied to the silicon surface, changing the drain electrode.
そうすると差動回路により、測定溶液の温度変化やpH
変化が補償されて、アドレナリンの濃度のみに依存する
出力が差動増幅器24により得られ、第4図のような出
力結果が得られる。Then, the differential circuit changes the temperature change and pH of the measurement solution.
The changes are compensated for and an output dependent only on the concentration of adrenaline is obtained by the differential amplifier 24, resulting in an output result as shown in FIG.
発明の効果
以上のように、本発明の効果としては、一つの基板上に
フラビン含有のアドレナリンモノアミンオキシダーゼを
固定化した膜で覆った測定1)H−ISFET と固定
化膜をつけない参照pH−l5FETの2つを用意し、
従来では得られなかった小型でかつ測定が簡単で、安価
で、溶液の温度やpH変化に影響されず、温度補償が不
要で、いろいろな種類の物質が共存していても、この酵
素には選択性があるので、アドレナリンしか作用しない
検出センサを提供することができる。なお、この検出セ
ンサはインビボ(in vivo(生体内の局所情報
をそのままソース・ドレイン間の電流で計測することが
できる)〕においても測測定能である。Effects of the Invention As described above, the effects of the present invention are as follows: 1) Measurement using H-ISFET and reference pH- without the immobilized membrane on one substrate. Prepare two l5FETs,
This enzyme is compact, easy to measure, inexpensive, unaffected by temperature and pH changes of the solution, does not require temperature compensation, and can be used even in the coexistence of various types of substances. The selectivity makes it possible to provide a detection sensor that only acts on adrenaline. Note that this detection sensor is also capable of measuring in vivo (local information within a living body can be directly measured using a current between a source and a drain).
第1図(a)は本発明の一実施例におけるアドレナリン
測定pH−l5F’ETの平面図、第1図(b)は同図
<a>のI −1’面における断面図、第2図(a、)
は本実施例における参照pH−l8FETの平面図、第
2図(b)は同図(a)の1−1′面における断面図、
第3図は本実施例のアドレナリン検出用pH−l5FE
T の測定回路図、第4図はアドレナリンの濃度とソー
ス・ドレイン間の電流の関係図、第5図は従来法におけ
るアドレナリンを含むカテコールアミンおよび代謝物の
酸化による電流値と濃度の関係図である。
1・・・P−型シリコン、21ドレイznM域、2・・
・:/−スn lJ域、3・・・P−型のチャンネル
、4・・・チャンネルストツバ−(P)、5・・・ソー
ス電極、5・・・ソース電極AJ端子、6・・・ドレイ
ン電極、6、・・ドレイン電極AJ端子、7・・・5i
02.8・・・Si3N4. 9・・・エポキシとシリ
コンの混合樹脂、10・・・フラピ、ン含有のアドレナ
リンモノアミンオキシダーゼ固定化膜、11・・2測定
pH−FET 。
12・・・参照pH−FET、13・・・Ag /Ag
C1基準極、24・・・差動増幅器。
代理人の氏名 弁理士 粟 野 重 孝ほか1名第1図
(α)6、t−x*踵
tOTa’:i!、イt=S
第2図
(Q)
(b)
第3図
fδFIG. 1(a) is a plan view of adrenaline measurement pH-15F'ET in one embodiment of the present invention, FIG. 1(b) is a cross-sectional view on the I-1' plane of the same figure <a>, and FIG. (a,)
is a plan view of the reference pH-18FET in this example, and FIG. 2(b) is a cross-sectional view taken along the plane 1-1' of FIG.
Figure 3 shows pH-15FE for adrenaline detection in this example.
Figure 4 is a diagram showing the relationship between the concentration of adrenaline and current between source and drain. Figure 5 is a diagram showing the relationship between current value and concentration due to oxidation of catecholamines and metabolites including adrenaline in the conventional method. . 1...P-type silicon, 21 Drai znM region, 2...
・:/-sn lJ region, 3... P- type channel, 4... Channel stopper (P), 5... Source electrode, 5... Source electrode AJ terminal, 6...・Drain electrode, 6,...Drain electrode AJ terminal, 7...5i
02.8...Si3N4. 9... Mixed resin of epoxy and silicone, 10... Adrenaline monoamine oxidase immobilized membrane containing flapine, 11... 2 measurement pH-FET. 12...Reference pH-FET, 13...Ag/Ag
C1 reference pole, 24...differential amplifier. Name of agent: Patent attorney Shigetaka Awano and one other person Figure 1 (α) 6, t-x*heel tOTa': i! , it=S Fig. 2 (Q) (b) Fig. 3 fδ
Claims (1)
と反応してpHを変えるフラビン含有のアドレナリンモ
ノアミンオキシダーゼを固定化した膜で被覆した測定p
H−電界効果トランジスタと被覆しない参照pH−電界
効果トランジスタを用意し、両者のpH−電界効果トラ
ンジスタの差動手段とを設けたアドレナリン検出センサ
。pH - measurement p coated on the gate of a field effect transistor with a membrane immobilized with flavin-containing adrenaline monoamine oxidase, which reacts with adrenaline and changes the pH.
An adrenaline detection sensor comprising an H-field effect transistor and an uncovered reference pH-field effect transistor, and differential means for both pH-field effect transistors.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1130818A JPH02309241A (en) | 1989-05-24 | 1989-05-24 | Adrenalin detection sensor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1130818A JPH02309241A (en) | 1989-05-24 | 1989-05-24 | Adrenalin detection sensor |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH02309241A true JPH02309241A (en) | 1990-12-25 |
Family
ID=15043431
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1130818A Pending JPH02309241A (en) | 1989-05-24 | 1989-05-24 | Adrenalin detection sensor |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH02309241A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003073088A2 (en) * | 2001-03-09 | 2003-09-04 | Christofer Toumazou | Apparatus and method for the detection of localised fluctuactions of ionic charge by ion sensitive field effect transistors during a chemical reaction |
US8114591B2 (en) | 2001-03-09 | 2012-02-14 | Dna Electronics Ltd. | Sensing apparatus and method |
CN104101633A (en) * | 2014-07-29 | 2014-10-15 | 无锡百灵传感技术有限公司 | Method for preparing electrochemical sensor based on carbon nano tube and vinyl ferrocene modified carbon paste electrode |
-
1989
- 1989-05-24 JP JP1130818A patent/JPH02309241A/en active Pending
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003073088A2 (en) * | 2001-03-09 | 2003-09-04 | Christofer Toumazou | Apparatus and method for the detection of localised fluctuactions of ionic charge by ion sensitive field effect transistors during a chemical reaction |
WO2003073088A3 (en) * | 2001-03-09 | 2003-11-20 | Christofer Toumazou | Apparatus and method for the detection of localised fluctuactions of ionic charge by ion sensitive field effect transistors during a chemical reaction |
GB2389424B (en) * | 2001-03-09 | 2004-11-24 | Christofer Toumazou | Sensing apparatus and method |
US7686929B2 (en) | 2001-03-09 | 2010-03-30 | Dna Electronics Limited | Sensing apparatus and method |
US7888015B2 (en) | 2001-03-09 | 2011-02-15 | Dna Electronics Ltd. | qPCR using solid-state sensing |
US8114591B2 (en) | 2001-03-09 | 2012-02-14 | Dna Electronics Ltd. | Sensing apparatus and method |
US8685228B2 (en) | 2001-03-09 | 2014-04-01 | Dna Electronics Limited | Sensing apparatus and method |
US8698211B2 (en) | 2001-03-09 | 2014-04-15 | Dna Electronics Ltd. | Sensing apparatus and method |
CN104101633A (en) * | 2014-07-29 | 2014-10-15 | 无锡百灵传感技术有限公司 | Method for preparing electrochemical sensor based on carbon nano tube and vinyl ferrocene modified carbon paste electrode |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Soldatkin et al. | Creatinine sensitive biosensor based on ISFETs and creatinine deiminase immobilised in BSA membrane | |
Sant et al. | Development of chemical field effect transistors for the detection of urea | |
Gotoh et al. | Acetylcholine sensor based on ion sensitive field effect transistor and acetylcholine receptor | |
US5387328A (en) | Bio-sensor using ion sensitive field effect transistor with platinum electrode | |
Soldatkin et al. | Glucose-sensitive field-effect transistor with additional Nafion membrane: reduction of influence of buffer capacity on the sensor response and extension of its dynamic range | |
Sant et al. | Development of a creatinine-sensitive sensor for medical analysis | |
Bian et al. | A field effect transistor (FET)-based immunosensor for detection of HbA1c and Hb | |
Poghossian | Method of fabrication of ISFET-based biosensors on an Si–SiO2–Si structure | |
Soldatkin et al. | Development of potentiometric creatinine-sensitive biosensor based on ISFET and creatinine deiminase immobilised in PVA/SbQ photopolymeric membrane | |
Stefan-van Staden et al. | Amperometric biosensor based on diamond paste for the enantioanalysis of L-lysine | |
Tahara et al. | Electrochemical reference electrode for the ion-selective field effect transistor | |
ANZAI et al. | Urea sensor based on an ion-sensitive field effect transistor. IV. Determination of urea in human blood | |
JPH02309241A (en) | Adrenalin detection sensor | |
Hirst et al. | Electrodes in clinical chemistry | |
JPS58184540A (en) | Biochemical detecting element and method for measuring concentration of compound using the same | |
JPH02309244A (en) | Serotonin detection sensor | |
EP0241991A2 (en) | Field effect transistor having a membrane overlying the gate insulator | |
JPH02309243A (en) | Dopamine detection sensor | |
Hsieh et al. | High-performance extended gate field-effect-transistor-based dissolved carbon dioxide sensing system with a packaged microreference electrode | |
JPH02309245A (en) | Acetylcholine detection sensor | |
JPH02309242A (en) | Noradrenalin detection sensor | |
JPH055059B2 (en) | ||
US8410530B2 (en) | Sensitive field effect transistor apparatus | |
JPS62132160A (en) | Biosensor using separation gate type isfet | |
JPS6189553A (en) | Integrated enzyme fet |